0,931  0,001  Pneumotoxic
0,677  0,004  Skeletal muscle relaxant
0,599  0,005  Muscle relaxant
0,605  0,012  Spasmolytic
0,543  0,029  Antiparkinsonian
0,453  0,005  Toxic, respiratory center
0,456  0,011  Anesthetic general
0,477  0,033  Vasodilator, peripheral
0,432  0,004  Dopamine D1 antagonist
0,434  0,010  Antiseptic
0,414  0,023  Cardiodepressant
0,397  0,008  Tyrosine 3 hydroxylase inhibitor
0,389  0,005  Alpha 2 adrenoreceptor antagonist
0,412  0,030  NOS2 expression inhibitor
0,439  0,064  TNF expression inhibitor
0,455  0,081  Caspase 9 stimulant
0,406  0,037  Cardioprotectant
0,402  0,047  Aldehyde oxidase inhibitor
0,374  0,021  Antiarrhythmic
0,382  0,030  Tumour necrosis factor alpha release inhibitor
0,395  0,047  5 Hydroxytryptamine release stimulant
0,364  0,020  P-glycoprotein inhibitor
0,385  0,044  Antiischemic
0,387  0,055  Prostate cancer treatment
0,362  0,032  Amyloid beta aggregation inhibitor
0,363  0,038  Huntington's disease treatment
0,348  0,026  5 Hydroxytryptamine uptake stimulant
0,327  0,008  Antitussive
0,339  0,021  Sleep disorders treatment
0,380  0,068  Transcription factor NF kappa B inhibitor
0,362  0,053  CYP2D6 substrate
0,317  0,016  Amylase inhibitor
0,319  0,024  Antihypotensive
0,341  0,049  Antioxidant
0,334  0,055  CTGF expression inhibitor
0,289  0,016  Alpha adrenoreceptor antagonist
0,287  0,015  Toll-Like receptor 9 antagonist
0,329  0,058  CYP2D6 inhibitor
0,349  0,079  Stroke treatment
0,338  0,070  Mood disorders treatment
0,316  0,050  Cardiotonic
0,275  0,010  Toll-Like receptor antagonist
0,286  0,021  Tubulin antagonist
0,287  0,022  Neurotrophic factor enhancer
0,323  0,060  Sodium/bile acid cotransporter inhibitor
0,329  0,067  Apoptosis antagonist
0,290  0,030  Antianginal
0,257  0,009  Acetylcholine nicotinic antagonist
0,337  0,089  Antiasthmatic
0,277  0,036  Myocardial ischemia treatment
0,248  0,009  Alpha 2a adrenoreceptor antagonist
0,246  0,008  Phosphodiesterase 4D inhibitor
0,254  0,018  Cocaine dependence treatment
0,345  0,111  Analgesic
0,280  0,049  Antimitotic
0,251  0,021  Cholinergic antagonist
0,305  0,076  Antidepressant
0,249  0,020  Acetylcholine antagonist
0,235  0,009  Movement disorders treatment
0,252  0,027  Antiparkinsonian, tremor relieving
0,278  0,058  Free radical scavenger
0,342  0,123  Calcium channel L-type activator
0,272  0,054  Cyclic AMP phosphodiesterase inhibitor
0,309  0,096  CYP3A4 substrate
0,271  0,062  Superoxide dismutase inhibitor
0,278  0,069  UGT1A9 substrate
0,282  0,076  Antineoplastic (pancreatic cancer)
0,277  0,072  UGT2B4 substrate
0,248  0,048  UGT1A1 substrate
0,232  0,032  Protein kinase stimulant
0,304  0,107  Toll-Like receptor 7 agonist
0,307  0,111  Antiobesity
0,202  0,008  Prolactin inhibitor
0,221  0,030  UGT2B9 substrate
0,335  0,148  Apoptosis agonist
0,307  0,120  CYP2C19 inhibitor
0,214  0,028  UGT2B10 substrate
0,279  0,095  AR expression inhibitor
0,297  0,113  Toll-Like receptor agonist
0,220  0,038  LDLR expression enhancer
0,331  0,150  MAP kinase 1 inhibitor
0,200  0,018  Bronchodilator
0,195  0,014  Dementia treatment
0,190  0,014  Vascular dementia treatment
0,288  0,115  Cognition disorders treatment
0,282  0,111  Antileukemic
0,226  0,057  DNA methyltransferase I inhibitor
0,277  0,109  Antineoplastic (endocrine cancer)
0,228  0,065  Antineoplastic enhancer
0,209  0,046  UGT1A3 substrate
0,199  0,038  Uterine stimulant
0,182  0,021  Dopamine antagonist
0,265  0,103  CYP3A4 inhibitor
0,187  0,027  Antiadrenergic
0,198  0,041  Anesthetic
0,167  0,011  Neuronal nicotinic receptor antagonist
0,208  0,051  Antimutagenic
0,191  0,034  Antinephritic
0,311  0,157  Alzheimer's disease treatment
0,198  0,047  Cholinergic
0,180  0,030  Cystathionine beta-synthase inhibitor
0,175  0,028  Adrenaline antagonist
0,160  0,016  Electron transport complex I inhibitor
0,270  0,126  Ulceration
0,163  0,021  Dopamine D2 antagonist
0,189  0,047  UGT2B15 substrate
0,268  0,126  Calcium channel activator
0,214  0,074  Antihypertriglyceridemic
0,210  0,070  Septic shock treatment
0,212  0,073  Cytotoxic
0,204  0,065  CYP2B6 inhibitor
0,206  0,067  UDP-glucuronosyltransferase substrate
0,209  0,073  DNA methylase inhibitor
0,269  0,134  Antineoplastic (breast cancer)
0,197  0,061  VEGF expression inhibitor
0,162  0,027  Alpha 2c adrenoreceptor antagonist
0,175  0,043  Antifungal enhancer
0,174  0,042  Acetylcholinesterase inhibitor
0,254  0,123  Antithrombotic
0,135  0,005  Potassium channel (Ca-activated) blocker
0,217  0,088  Antiamyloidogenic
0,189  0,063  UGT1A4 substrate
0,156  0,032  Antischistosomal
0,206  0,082  VCAM1 expression inhibitor
0,238  0,114  FMO3 substrate
0,217  0,093  Antineoplastic (liver cancer)
0,178  0,055  Catenin beta inhibitor
0,205  0,082  Dependence treatment
0,250  0,127  FMO1 substrate
0,188  0,065  Male reproductive disfunction treatment
0,215  0,093  Vasodilator
0,183  0,061  Urinary incontinence treatment
0,146  0,027  HIV-1 integrase (Overall Integration) inhibitor
0,190  0,071  Hepatoprotectant
0,174  0,056  Acetylcholine M1 receptor antagonist
0,171  0,053  Antineoplastic (squamous cell carcinoma)
0,132  0,018  Tocolytic
0,221  0,108  Antipsychotic
0,118  0,005  Potassium channel small-conductance Ca-activated blocker
0,242  0,130  ICAM1 expression inhibitor
0,142  0,031  Alpha 1 adrenoreceptor antagonist
0,202  0,092  UGT1A6 substrate
0,240  0,130  Antiallergic
0,122  0,012  Phosphodiesterase 4A inhibitor
0,228  0,119  CYP1A2 substrate
0,228  0,121  Hypoxia-inducible factor 1 alpha inhibitor
0,126  0,019  Dopamine agonist
0,220  0,114  CYP2C19 substrate
0,206  0,101  Antihypercholesterolemic
0,135  0,030  Vasculitis treatment
0,231  0,130  Caspase 3 stimulant
0,215  0,114  5 Hydroxytryptamine 1E antagonist
0,242  0,142  Vasodilator, coronary
0,134  0,034  Chronic obstructive bronchitis treatment
0,153  0,057  Adenylate cyclase stimulant
0,179  0,085  Antimigraine
0,145  0,052  Antihelmintic (Trematoda)
0,167  0,075  ATPase inhibitor
0,134  0,042  Expectorant
0,128  0,037  Acetylcholine release stimulant
0,182  0,091  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,153  0,064  Attention deficit/hyperactivity disorder treatment
0,137  0,050  Antineoplastic (uterine cancer)
0,198  0,110  Acute neurologic disorders treatment
0,125  0,038  Sphingomyelinase inhibitor
0,115  0,028  Adrenaline agonist
0,106  0,020  Narcotic antagonist
0,164  0,078  UGT2B7 substrate
0,153  0,067  Lipid peroxidase inhibitor
0,104  0,018  Dopamine uptake inhibitor
0,162  0,078  Sigma receptor agonist
0,099  0,015  Phosphodiesterase 4C inhibitor
0,136  0,053  Acetylcholine muscarinic antagonist
0,132  0,049  Alpha 2b adrenoreceptor antagonist
0,094  0,013  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,164  0,084  Tumour necrosis factor antagonist
0,127  0,050  SULT1A1 substrate
0,173  0,098  Psychostimulant
0,140  0,066  Phosphodiesterase inhibitor
0,202  0,129  Antineurogenic pain
0,193  0,120  Hypoglycemic
0,160  0,087  Nitric oxide antagonist
0,077  0,005  Vesicle monoamine transporter inhibitor
0,090  0,018  Uterine relaxant
0,086  0,015  Glycine transporter inhibitor
0,139  0,069  Neurotrophic factor
0,195  0,126  Radioprotector
0,133  0,065  Antihemorrhagic
0,124  0,056  5 Hydroxytryptamine 2 antagonist
0,143  0,079  Antiviral (Influenza A)
0,114  0,051  Butyrylcholinesterase inhibitor
0,120  0,056  Estrogen antagonist
0,078  0,015  Dopamine D2 agonist
0,076  0,013  Dopamine D5 antagonist
0,112  0,051  Sulfotransferase substrate
0,093  0,032  Estrogen receptor alpha antagonist
0,197  0,136  Antineoplastic (colorectal cancer)
0,156  0,096  Antineoplastic (gastric cancer)
0,179  0,119  Urologic disorders treatment
0,134  0,075  Nav1.6 sodium channel blocker
0,197  0,138  Chemoprotective
0,146  0,089  Hearing loss treatment
0,106  0,050  UGT2B11 substrate
0,095  0,040  Opioid kappa receptor antagonist
0,203  0,147  NOS3 expression inhibitor
0,180  0,125  Cardiovascular analeptic
0,121  0,066  Anesthetic local
0,091  0,037  Analgesic, opioid
0,080  0,027  5 Hydroxytryptamine 2A agonist
0,081  0,029  Beta tubulin antagonist
0,114  0,061  EphA2 antagonist
0,098  0,046  Phosphodiesterase IV inhibitor
0,126  0,074  Vanilloid 1 agonist
0,091  0,039  Alpha 1b adrenoreceptor antagonist
0,108  0,057  Antihypermotility
0,150  0,100  Aldehyde oxidase substrate
0,233  0,183  Antipruritic, allergic
0,157  0,108  Antiviral (Influenza)
0,090  0,041  Estrogen-related receptor beta agonist
0,222  0,175  CYP2C9 substrate
0,089  0,041  Nicotinic alpha4beta2 receptor antagonist
0,182  0,135  Antineoplastic (colon cancer)
0,116  0,070  Constipation treatment
0,158  0,112  Antineoplastic (glioblastoma multiforme)
0,134  0,088  Genotoxic
0,066  0,023  Ryanodine receptor antagonist
0,073  0,030  Beta 3 adrenoreceptor antagonist
0,202  0,160  Antineoplastic (lung cancer)
0,103  0,063  Nav1.1 sodium channel blocker
0,072  0,032  NMDA 2C receptor antagonist
0,089  0,049  Vanilloid agonist
0,142  0,102  Interleukin 6 antagonist
0,066  0,027  NMDA 2B receptor antagonist
0,096  0,058  Bile acid receptor antagonist
0,123  0,084  Erectile dysfunction treatment
0,113  0,075  Alkylator
0,100  0,064  Estrogen receptor beta antagonist
0,050  0,013  Estrogen-related receptor alpha antagonist
0,051  0,015  Nicotinic receptor beta4 subunit antagonist
0,060  0,025  Dopamine transporter inhibitor
0,188  0,153  Radiosensitizer
0,076  0,041  Alpha adrenoreceptor agonist
0,167  0,133  Antineoplastic (non-small cell lung cancer)
0,039  0,005  Dopamine D1 agonist
0,102  0,069  UGT2B1 substrate
0,070  0,038  Beta adrenoreceptor antagonist
0,061  0,029  5 Hydroxytryptamine 7 agonist
0,134  0,103  Interferon gamma antagonist
0,134  0,102  Heat shock protein 70 antagonist
0,089  0,058  Opioid antagonist
0,127  0,098  Chemopreventive
0,163  0,134  Antiviral (HIV)
0,107  0,078  Microtubule formation inhibitor
0,076  0,047  Alpha 1a adrenoreceptor antagonist
0,101  0,074  DOPA decarboxylase inhibitor
0,065  0,039  Dopamine D4 antagonist
0,046  0,021  Dopamine D5 agonist
0,066  0,042  5 Hydroxytryptamine uptake inhibitor
0,176  0,153  Respiratory analeptic
0,099  0,077  Nav1.4 sodium channel blocker
0,073  0,051  Nav1.8 sodium channel blocker
0,177  0,155  Proliferative diseases treatment
0,068  0,046  Female sexual dysfunction treatment
0,053  0,031  Beta 2 adrenoreceptor antagonist
0,166  0,144  Myocardial infarction treatment
0,052  0,030  Nicotinic receptor alpha4 subunit antagonist
0,052  0,031  Sodium/calcium exchanger inhibitor
0,055  0,035  Alpha tubulin antagonist
0,049  0,030  Opioid mu receptor agonist
0,169  0,149  Peptidyltransferase inhibitor
0,219  0,199  Antineoplastic (small cell lung cancer)
0,125  0,107  Antidiarrheal
0,087  0,069  SULT1E1 substrate
0,052  0,035  Glucose-6-phosphate translocase inhibitor
0,059  0,043  Bcl-xL inhibitor
0,038  0,022  Glycine transporter 1 inhibitor
0,045  0,028  Opioid kappa receptor agonist
0,062  0,047  5 Hydroxytryptamine 1D antagonist
0,109  0,094  Antifungal (Pneumocystis)
0,043  0,029  Estradiol 17 beta-dehydrogenase inhibitor
0,074  0,059  Somatostatin 1 agonist
0,155  0,141  Antialcoholic
0,060  0,047  Opioid delta receptor antagonist
0,112  0,099  Skin whitener
0,067  0,054  HIV-1 integrase inhibitor
0,183  0,171  12-Lipoxygenase inhibitor
0,065  0,054  5 Hydroxytryptamine 1F antagonist
0,141  0,129  Succinate dehydrogenase inhibitor
0,058  0,047  5 Hydroxytryptamine 7 antagonist
0,093  0,083  Toll-Like receptor 4 antagonist
0,051  0,041  Nicotinic alpha3beta2 receptor antagonist
0,020  0,010  Antibiotic Trimethoprim-like
0,062  0,052  Opioid mu receptor antagonist
0,085  0,075  MAO A inhibitor
0,100  0,091  M18 aspartyl aminopeptidase inhibitor
0,059  0,049  Heme oxygenase stimulant
0,062  0,053  Orexin receptor antagonist
0,069  0,060  Orexin receptor 1 antagonist
0,083  0,076  Breast cancer-resistant protein inhibitor
0,076  0,070  Antineoplastic alkaloid
0,071  0,066  5 Hydroxytryptamine 2A antagonist
0,092  0,087  Antiinfertility, female
0,021  0,017  Urotensin II antagonist
0,056  0,052  Narcolepsy treatment
0,126  0,121  Liver fibrosis treatment
0,042  0,039  Antibiotic Glycopeptide-like
0,105  0,102  Nav1.2 sodium channel blocker
0,021  0,019  Beta 1 adrenoreceptor agonist
0,054  0,052  Adrenaline uptake inhibitor
0,141  0,139  Abortion inducer
0,015  0,014  Thyroid hormone alpha agonist
0,123  0,122  Antihelmintic (Nematodes)
0,048  0,048  Vanilloid 2 antagonist
0,093  0,092  5 Hydroxytryptamine 2B antagonist
0,036  0,036  Acid-sensing ion channel blocker

